{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:28:48Z","timestamp":1787146128456,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/inf.0b013e318262528c","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T06:50:52Z","timestamp":1338965452000},"page":"1069-1073","source":"Crossref","is-referenced-by-count":11,"title":["Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years"],"prefix":"10.1097","volume":"31","author":[{"given":"Ameneh","family":"Khatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wysocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Westcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcisa","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Peddiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominigue","family":"Boutriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3201\/eid1603.090290","article-title":"European Union Invasive Bacterial Infection Surveillance participants. Invasive Haemophilus influenzae Disease, Europe, 1996-2006.","volume":"16","author":"Ladhani","year":"2010","journal-title":"Emerging Infect Dis"},{"key":"R2-17-20210202","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S0950268806007382","article-title":"Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom.","volume":"135","author":"Ladhani","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/INF.0b013e3181f728fd","article-title":"Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.","volume":"30","author":"Khatami","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines.","volume":"113","author":"Kelly","year":"2004","journal-title":"Immunology"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/adc.2007.136036","article-title":"A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.","volume":"93","author":"Pace","year":"2008","journal-title":"Arch Dis Child"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/INF.0b013e31813429fa","article-title":"A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.","volume":"26","author":"Pace","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"Kayhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(87)90289-4","article-title":"Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).","volume":"103","author":"Karpinski","year":"1987","journal-title":"J Immunol Methods"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02097184","article-title":"Acellular pertussis vaccine in adults: adverse reactions and immune response.","volume":"6","author":"Granstrom","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"R13-17-20210202","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"R16-17-20210202","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0264-410X(00)00241-3","article-title":"A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants.","volume":"19","author":"English","year":"2000","journal-title":"Vaccine"},{"key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"R20-17-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/S0950268804002122","article-title":"Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom.","volume":"132","author":"McVernon","year":"2004","journal-title":"Epidemiol Infect"},{"key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e318262528c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:31:45Z","timestamp":1620941505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201210000-00017"}},"subtitle":["A Follow-up Study"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318262528c","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717952623.793458129","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}